ABIN1673217
antibody from antibodies-online
Targeting: GZMB
CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1673217 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Granzyme B (Granzyme 2, Cytotoxic T-Lymphocyte-Associated serine Esterase 1) (Gzmb) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to a sequence at the C-terminal of human Granzyme B.Immunogen affinity purified.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for a longer time.
- Handling
- Avoid repeated freezing and thawing.
Submitted references A novel NF-kappaB binding site controls human granzyme B gene transcription.
Aberrant recombination involving the granzyme locus occurs in Atm-/- T-cell lymphomas.
Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.
Huang C, Bi E, Hu Y, Deng W, Tian Z, Dong C, Hu Y, Sun B
Journal of immunology (Baltimore, Md. : 1950) 2006 Apr 1;176(7):4173-81
Journal of immunology (Baltimore, Md. : 1950) 2006 Apr 1;176(7):4173-81
Aberrant recombination involving the granzyme locus occurs in Atm-/- T-cell lymphomas.
Winrow CJ, Pankratz DG, Vibat CR, Bowen TJ, Callahan MA, Warren AJ, Hilbush BS, Wynshaw-Boris A, Hasel KW, Weaver Z, Lockhart DJ, Barlow C
Human molecular genetics 2005 Sep 15;14(18):2671-84
Human molecular genetics 2005 Sep 15;14(18):2671-84
Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.
Motyka B, Korbutt G, Pinkoski MJ, Heibein JA, Caputo A, Hobman M, Barry M, Shostak I, Sawchuk T, Holmes CF, Gauldie J, Bleackley RC
Cell 2000 Oct 27;103(3):491-500
Cell 2000 Oct 27;103(3):491-500
No comments: Submit comment
No validations: Submit validation data